Marital status has been reported to be associated with survival in patients with several types of cancer, including acute myeloid leukemia, and those receiving solid organ transplantation [1] [2] [3] [4] [5] . However, there have been no reports detailing the impact of marital status on outcomes after allogeneic hematopoietic cell transplantation (HCT). In this study, we retrospectively analyzed whether marital status at the time of HCT affected the outcomes of allogeneic HCT in 309 adult patients with hematological diseases at our institute.
To clarify the impact of marital status on transplant outcomes, we analyzed data from the first allogeneic HCT for 309 patients aged older than 20 years at our institute between January 2000 to January 2017. During the study period, monogamy is the rule of marriage in Japan. The probability of overall survival (OS) was estimated according to the Kaplan-Meier method, and the groups were compared using the log-rank test. The risks of relapse, transplant-related mortality (TRM), acute graft-versus-host disease (aGVHD), and chronic graft-versus-host disease (cGVHD) were estimated based on a cumulative incidence method to accommodate competing risks, and the groups were compared using Gray's test. A multivariate analysis was performed with a Cox proportional hazard model for overall mortality or a Fine and Gray proportional hazards model for others using these factors: marital status (yes vs. no), age (<45 vs. ≥45 years), sex (male vs. female), recipient cytomegalovirus serostatus (positive vs. negative), disease status at HCT (standard risk vs. high risk), donor source [bone marrow transplantation/peripheral blood stem cell transplantation from an HLA matched-related donor (MRBMT/PBSCT) vs. bone marrow transplantation/peripheral blood stem cell transplantation from an HLA mismatched-related donor (MMRBMT/PBSCT) vs. BMT from an unrelated donor (UBMT) vs. cord blood transplantation from an unrelated donor (UCBT)], conditioning regimen [myeloablative conditioning (MAC) vs. reducedintensity conditioning (RIC)], ABO compatibility between donor and recipient (match vs. mismatch), and year of HCT (2000-2006 vs. 2007-2017) . The disease status at HCT was classified as standard or high risk based on the risk scoring scheme of the American Society for Blood and Marrow Transplantation Request for Information 2006 risk scoring schema, as previously described [6] . Acute leukemia in the first or second complete remission, myelodysplastic syndrome (MDS), myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML) without excessive numbers of blasts, chronic myelogenous leukemia (CML) in the first chronic phase, Hodgkin's or non-Hodgkin's lymphoma in complete or partial chemotherapysensitive remission, and severe aplastic anemia were classified as standard risk; all other situations were classified as high risk. The MAC regimen was defined according to the criteria of the Center for International Blood and Marrow Transplant Research (CIBMTR), and others were classified as RIC [7] . All statistical analyses were performed with EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan) [8] , a graphical user interface for R 3.0.2 (R Foundation for Statistical Computing, Vienna, Austria). P values of <0.05 were considered to be significant. This retrospective study was approved by the institutional review board of the Institute of Medical Science, the University of Tokyo.
These authors contributed equally: Tomoko Sato, Takaaki Konuma. The characteristics of patients are shown in Table 1 . The median age was 43 years (range, 20-68 years). The most common disease type was acute myeloid leukemia (50%). Forty patients received MBMT/PBSCT, 9 received MMRBMT/PBSCT, 21 received UBMT, and 239 received UCBT. The majority of conditioning regimens were MAC (94%), and the most common GVHD prophylaxis was cyclosporine A and methotrexate (84%). Among the entire cohort, 201 patients were married and 108 patients were unmarried, including widowed, divorced, and nevermarried patients. There were no significant differences between the two groups, except that married patients were older than unmarried patients (P < 0.001).
With a median follow-up of 82 months (range, 3-209 months) for survivors, the probability of OS at 5 years was 65% (95% confidence interval [CI]: 58-72%) for married patients and 73% (95% CI: 63-81%) for unmarried patients (P = 0.25, Fig. 1a) . The cumulative incidence of relapse at 5 years was 25% (95% CI: 19-32%) for married patients and 21% (95% CI: 14-30%) for unmarried patients (P = 0.71, Fig. 1b) . The cumulative incidence of TRM at 5 years was 16% (95% CI: 11-22%) for married patients and 9% (95% CI: 4-15%) for unmarried patients (P = 0.10, Fig. 1c ). There were no significant differences in the cumulative incidences of grade II-IV aGVHD (P = 0.83, Fig. 1d ), grade III-IV aGVHD (P = 0.68, Fig. 1d ), and HCT hematopoietic cell transplantation, CMV cytomegalovirus, MRBMT/PBSCT bone marrow transplantation/peripheral blood stem cell transplantation from an HLA matched-related donor, MMRBMT/PBSCT bone marrow transplantation/peripheral blood stem cell transplantation from an HLA mismatched-related donor, UBMT bone marrow transplantation from an unrelated donor, UCBT cord blood transplantation from an unrelated donor, MAC myeloablative conditioning, RIC reduced-intensity conditioning, GVHD graft-versus-host disease. The P value in bold is statistically significant Table 2 ). Marital status did not affect 
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HCT hematopoietic cell transplantation, CMV cytomegalovirus, MRBMT/PBSCT bone marrow transplantation/peripheral blood stem cell transplantation from an HLA matched-related donor, MMRBMT/PBSCT bone marrow transplantation/peripheral blood stem cell transplantation from an HLA mismatched-related donor, UBMT bone marrow transplantation from an unrelated donor, UCBT cord blood transplantation from an unrelated donor, MAC myeloablative conditioning, RIC reduced-intensity conditioning, HR hazard ratio, CI confidence interval. The P values in bold are statistically significant the development of grade II-IV aGVHD, grade III-IV aGVHD, and extensive cGVHD in multivariate analysis (Supplementary Table 1) . Female sex significantly affected overall mortality and TRM in multivariate analysis. In addition, the proportion of age older than 45 years were significantly higher in married patients compared with unmarried patients (P < 0.001). Therefore, we also performed a subgroup analysis according to sex (male or female) and age (<45 or ≥45 years), but marital status did not affect transplant outcomes in the univariate or multivariate analyses ( Supplementary Figure 1, Supplementary Table 2 , and Supplementary Table 3) .
Several studies have shown that marital status affected cancer-specific mortality among patients with solid cancer and acute myeloid leukemia [1] [2] [3] [4] , whereas other studies have not [9] . The reason for the correlation of marital status and improved cancer-specific survival has been unclear, but one possible reason is that married patients have better adherence to prescribed treatments than unmarried patients [10] . Moreover, married patients show less depression and anxiety than unmarried patients because spouses can share the emotional burden of cancer. In fact, Ehrlich et al. [11] reported that pre-transplant emotional support was significantly associated with better outcomes after allogeneic HCT. Meanwhile, a meta-analysis study of solid organ transplant recipients showed marital status was not predictive of post-transplant adherence and outcomes [12] . Similarly, our study demonstrated that marital status did not affect transplant outcomes after allogeneic HCT. The different effects of marital status on cancer-specific mortality and post-transplant outcomes might be partly due to the difference in ages of the patient cohorts between cancer and transplants. Patients receiving transplants, particularly allogeneic HCT, are usually younger than patients with cancer. Unmarried patients receiving transplants seem to receive social support from their parents, siblings, and friends instead of spouses, suggesting that marital status is not associated with survival after allogeneic HCT.
Marital status influenced the use of definitive therapy in patients with cancer. Recently, Jabo et al. [13] showed that unmarried patients were significantly less likely to receive allogeneic HCT in patients with acute leukemia. Because the presence of caregivers is an essential part of allogeneic HCT for recipients and most of these caregivers are spouses, a lack of caregivers could contribute to the reduced utilization of allogeneic HCT in unmarried patients. Although our study was certainly subjected to the selection bias of patients who received allogeneic HCT, further studies are required to clarify the impact of marital status on the use of allogeneic HCT for patients who can benefit from it.
Our study had several limitations. First, this study was a single-institute analysis and the sample size of patients in each group was too small to clarify the impact of marital status on transplant outcomes. Therefore, our results might be modified by lower statistical power to detect true effects. Second, other socioeconomic status such as education, income, and employment may also affect the transplant outcomes. In addition, duration of marriage, marital status at some points after HCT, presence of caregivers, and presence of children might also contribute to the transplant outcomes. However, we were unable to use these socioeconomic profiles due to insufficient data in the medical records. Therefore, prospective multicenter studies are required to clarify the impact of socioeconomic status on the outcomes after allogeneic HCT in future. Third, majority of patients received CBT in our study, because unrelated cord blood is an alternative first-line treatment option for patients without a matched sibling donor. Therefore, the hierarchy of donor selection might raise the distinct possibility for patient selection bias, which could affect the transplant outcomes.
In conclusion, our results show that marital status did not affect survival, relapse, or TRM after allogeneic HCT. However, patient population with comparative survival between married and unmarried patients should be cautiously interpreted. Because the sample size of patients in each subgroup was small. Therefore, further studies with larger numbers of patients are warranted to confirm the impact of marital status on the outcomes after allogeneic HCT.
